Kessler Investment Group LLC trimmed its stake in shares of Petmed Express Inc (NASDAQ:PETS) by 38.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,284 shares of the company’s stock after selling 808 shares during the period. Kessler Investment Group LLC’s holdings in Petmed Express were worth $30,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. raised its holdings in shares of Petmed Express by 4.3% during the third quarter. BlackRock Inc. now owns 3,042,857 shares of the company’s stock valued at $100,446,000 after purchasing an additional 125,194 shares during the last quarter. Renaissance Technologies LLC increased its holdings in Petmed Express by 5.8% during the third quarter. Renaissance Technologies LLC now owns 1,748,415 shares of the company’s stock valued at $57,715,000 after buying an additional 96,215 shares during the last quarter. Epoch Investment Partners Inc. increased its holdings in Petmed Express by 71.4% during the third quarter. Epoch Investment Partners Inc. now owns 857,722 shares of the company’s stock valued at $28,313,000 after buying an additional 357,304 shares during the last quarter. Penserra Capital Management LLC increased its holdings in Petmed Express by 20.2% during the third quarter. Penserra Capital Management LLC now owns 485,493 shares of the company’s stock valued at $16,026,000 after buying an additional 81,648 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its holdings in Petmed Express by 3.8% during the third quarter. Bank of New York Mellon Corp now owns 349,341 shares of the company’s stock valued at $11,532,000 after buying an additional 12,731 shares during the last quarter. 95.04% of the stock is owned by hedge funds and other institutional investors.

PETS has been the subject of a number of research reports. BidaskClub cut shares of Petmed Express from a “buy” rating to a “hold” rating in a report on Saturday, September 22nd. ValuEngine cut shares of Petmed Express from a “sell” rating to a “strong sell” rating in a report on Monday, October 8th. Finally, TheStreet cut shares of Petmed Express from a “b” rating to a “c+” rating in a report on Thursday, November 29th. Three equities research analysts have rated the stock with a sell rating and two have assigned a hold rating to the company. The stock currently has a consensus rating of “Sell” and an average target price of $35.00.

Shares of PETS traded down $0.36 during mid-day trading on Friday, reaching $22.39. The stock had a trading volume of 20,047 shares, compared to its average volume of 586,929. The firm has a market cap of $502.79 million, a P/E ratio of 11.69 and a beta of 0.74. Petmed Express Inc has a 12 month low of $21.85 and a 12 month high of $57.80.

Petmed Express (NASDAQ:PETS) last posted its quarterly earnings results on Monday, October 22nd. The company reported $0.52 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.50 by $0.02. The business had revenue of $71.40 million during the quarter, compared to analyst estimates of $71.93 million. Petmed Express had a net margin of 14.88% and a return on equity of 35.53%. The company’s revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.43 earnings per share.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this piece of content can be accessed at https://theolympiareport.com/2019/01/11/kessler-investment-group-llc-decreases-stake-in-petmed-express-inc-pets.html.

About Petmed Express

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Featured Story: Balanced Fund

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Petmed Express Inc (NASDAQ:PETS).

Institutional Ownership by Quarter for Petmed Express (NASDAQ:PETS)

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.